OKYO Pharma company info

What does OKYO Pharma do?
OKYO Pharma ADR (NASDAQ:OKYO) is a biopharmaceutical company focused on developing innovative treatments to combat eye diseases, particularly those causing significant discomfort and vision impairment. Its pipeline of projects revolves around novel therapeutic peptides and small molecules aimed at addressing unmet needs in ophthalmology, with a keen emphasis on dry eye disease and chronic pain in ocular surfaces. OKYO Pharma's objective is to advance these cutting-edge therapies from the research stage through clinical trials, with the aim of eventually bringing new solutions to patients suffering from these debilitating conditions. The company is dedicated to improving quality of life through scientific breakthroughs and rigorous testing of their potential medications.
OKYO Pharma  company media
Company Snapshot

Is OKYO Pharma a public or private company?


How many people does OKYO Pharma employ?


What sector is OKYO Pharma in?

pie chart
Health Care

Where is the head office for OKYO Pharma ?

location pin
Head Office
London, United Kingdom

What year was OKYO Pharma founded?

founded flag
Year Founded
What does OKYO Pharma specialise in?
/Biopharmaceutical Company /Eye Disorder Treatments /Chronic Pain Therapies /Cannabinoid Research /Pharmaceutical Development /Healthcare Innovation

What are the products and/or services of OKYO Pharma ?

Overview of OKYO Pharma offerings
Development of novel therapeutics for ocular diseases focusing on dry eye disease.
Advancement of a proprietary GPCR agonist for treating ocular pain and inflammation.
Researching non-opioid, receptor-targeted therapeutics for chronic pain management.
Exploration of innovative treatments for age-related macular degeneration (AMD).
Investigation into novel drug delivery systems for enhanced ocular drug bioavailability.
Collaboration on biomedical research projects to identify potential new drug candidates for various diseases.

Who is in the executive team of OKYO Pharma ?

OKYO Pharma leadership team
  • Dr. Gary S. Jacob Ph.D.
    Dr. Gary S. Jacob Ph.D.
    CEO & Executive Director
  • Mr. Michael Paul Beck
    Mr. Michael Paul Beck
  • Ms. Keeren  Shah
    Ms. Keeren Shah
    Chief Financial Officer
  • Dr. William A. Clementi Ph.D., Pharm.D.
    Dr. William A. Clementi Ph.D., Pharm.D.
    Chief Operating Officer
  • Dr. Rajkumar  Patil Ph.D.
    Dr. Rajkumar Patil Ph.D.
    Chief Scientific Officer